Search clinical trials for: HIV latent reservoir

Total 13443 results

Erasmus Medical Center

Not yet recruiting

Studying Topiramate for Re-Activating the HIV-1 Reservoir (STAR)

HIV Infections | Hiv | HIV-1-infection | HIV I Infection

Netherlands
University Hospital, Ghent

Not yet recruiting

Analysis of the Reservoir in Individuals Controlling HIV Infection (ARCH)

Hiv
University Hospital, Strasbourg, France

Not yet recruiting

Analysis of the Persistence, Reservoir and HIV Latency (APRIL)

Informed Consent | HIV Infected Individuals
Hospital Universitari Vall d'Hebron Research Institute

Recruiting

Efficacy of Lauric Acid, a Dietary Fatty Acid, in Modifying the Latent Reservoir of HIV (FATHIV)

HIV Infections

Spain
Erasmus Medical Center

Recruiting

Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV (EX VIVO)

HIV Infections | HIV-1-infection | HIV-2 Infection

Netherlands
University Hospital, Ghent

Recruiting

HIV Study on MEasuring the Reservoir on Cellular Level to CUre Infection (HIV-Mercuri)

Hiv

Belgium
University of California, San Francisco

Recruiting

The Use of Leukapheresis to Support HIV Pathogenesis Studies

HIV

United States
National Institute of Allergy and Infectious Diseases...
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Completed

Quantitative Measurement and Correlates of the Latent HIV Reservoir in Virally Suppressed Ugandans

HIV

Uganda
University of Washington
National Institute of Allergy and Infectious Diseases (NIAID); National Center...

Enrolling by invitation

Comparing Immune Activation and Latent HIV Reservoir Size Between People Living With HIV on Tenofovir-containing Versus NRTI-free ART

Inflammation | HIV | HIV-1-infection | HIV Disease Progression

United States
University Hospital, Ghent

Withdrawn

Measuring the HIV-1 Reservoir During Cure Interventions Studies (MERCI)

Hiv

Belgium
The Wistar Institute
University of Pennsylvania; Merck Sharp & Dohme LLC

Completed

Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV

HIV-1 Infection

United States
University of Zurich

Active, not recruiting

BCG Vaccination Effect on Latent Reservoir Size in Treated HIV-1 Infection: (BELIEVE)

HIV-1-infection

Switzerland
Jean-Pierre Routy
Canadian Foundation for AIDS Research (CANFAR); CIHR Canadian HIV Trials Network

Completed

Valproic Acid and Its Effects on HIV Latent Reservoirs

HIV Infections

Canada
Mayo Clinic
Takeda

Completed

The Effect of Ixazomib on the Latent HIV Reservoir

Human Immunodeficiency Virus (HIV)

United States
University of North Carolina, Chapel Hill
ViiV Healthcare

Completed

Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection (PHI-05)

HIV | Acute HIV Infection

United States
National Institute of Allergy and Infectious Diseases...
AIDS Clinical Trials Group

Completed

Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults

HIV Infections

United States, Puerto Rico
Guangzhou 8th People's Hospital
Sun Yat-sen University

Completed

Effect of Chidamide Combined With CAT-T or TCR-T Cell Therapy on HIV-1 Latent Reservoir

HIV/AIDS

China
University of Melbourne
Johns Hopkins University; Oregon Health and Science University; University of... and other collaborators

Completed

HIV Persistence in Lymph Node and Peripheral Blood (HIV-PRADA)

HIV-1-infection

Australia
Erasmus Medical Center

Completed

LRAs United as a Novel Anti-HIV Strategy. (LUNA)

HIV-1-infection

Netherlands
Beijing 302 Hospital
Tsinghua University

Unknown

Third-Generation CAR-T-cell Therapy in Individuals With HIV-1 Infection (TCTIWHI)

HIV-1

China
Fred Hutchinson Cancer Center
University of Washington

Completed

MMF for HIV Reservoir Reduction

Human Immunodeficiency Virus I Infection

United States
University of California, San Francisco
Johns Hopkins University

Completed

Short-term Disulfiram Administration to Accelerate the Decay of the HIV Reservoir in Antiretroviral-treated HIV Infected Individuals

HIV-1 Infection

United States
University of California, San Francisco
National Institute of Allergy and Infectious Diseases (NIAID); Monash University and other collaborators

Completed

Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study

HIV | Human Immunodeficiency Virus

United States, Australia
Tang-Du Hospital
Chipscreen Biosciences, Ltd.

Completed

Chidamide in Combination With Antiretroviral Therapy for Eradication of the Latent HIV-1 Reservoir (CHARTER)

Chronic HIV Infections

China
St Vincent's Hospital, Sydney

Unknown

Identification and Quantification of HIV CNS Latency Biomarkers

HIV | HIV-associated Neurocognitive Disorder (HAND)

Australia
Tang-Du Hospital
Zhejiang University; Chipscreen Biosciences, Ltd.; First Affiliated Hospital...

Unknown

Chidamide in Combination With ART for Reactivation of the Latent HIV-1 Reservoir

Chronic HIV Infections

China
National Institute of Allergy and Infectious Diseases...

Completed

Daclizumab to Treat HIV-Infected Patients

HIV Infections

United States
Bionor Immuno AS
Celgene Corporation

Completed

Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reservoir (REDUC)

HIV I Infection

Denmark
Vaccine and Gene Therapy Institute, Florida
University of Miami

Withdrawn

Oral Auranofin for Reduction of Latent Viral Reservoir in Patients With HIV Infection (Goldrake)

HIV

United States
University Hospital, Montpellier
Université Montpellier; Centre National de la Recherche Scientifique, France

Not yet recruiting

Development of a New Family of HIV Latency Regulators (LRAs) Targeting the Tat Viral Protein (TatLat)

HIV Infections
Brigham and Women's Hospital
University of Cape Town; APIN Public Health Initiatives

Not yet recruiting

Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention

Latent Tuberculosis | Pediatric HIV Infection
Erasmus Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development; AI...

Not yet recruiting

Optimizing Reversal of HIV Latency With Combination Therapy (ORBIT)

Hiv

Netherlands
National Institute of Respiratory Diseases, Mexico
Hospital General Dr. Manuel Gea González; National Institute of Medical Sciences... and other collaborators

Not yet recruiting

Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico City (PREVALIOCDMX)

Acquired Immunodeficiency Syndrome | Cryptococcal Meningitis | Tuberculosis Infection | Histoplasmosis AIDS

Mexico
University of Aarhus
Aarhus University Hospital; The Alfred; The Peter Doherty Institute for Infection... and other collaborators

Recruiting

Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among People Living With HIV on ART (AMBER)

HIV-1-infection

Denmark
National Institute of Allergy and Infectious Diseases...

Recruiting

A Study to Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy

HIV-1

United States
First Affiliated Hospital of Zhejiang University

Recruiting

Immunomodulators on HIV-1 Reservoir

HIV Infections

China
National Cancer Institute (NCI)

Recruiting

Imaging and Biopsy of HIV-Infected Individuals Undergoing Analytic Treatment Interruption

HIV

United States
Baylor College of Medicine
London School of Hygiene and Tropical Medicine; Centers for Disease Control... and other collaborators

Recruiting

Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service (TB_GAPS)

Tuberculosis | HIV Coinfection | Tuberculosis Infection

Swaziland
Hôpital Européen Marseille

Recruiting

Evolution of HIV Reservoir, Inflammation and Microbiota Footprint of PLWH Switching to Long-acting Injectable Treatment Compared to Patients on Oral Dual or Triple Anti-integrase-based Therapy (LAMIVIH)

HIV Infections

France
University of Namibia
European and Developing Countries Clinical Trials Partnership (EDCTP); Research... and other collaborators

Recruiting

Collision of Three Global Pandemics: the Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Virological and Immunological Trajectory of COVID-19 in Botswana and Namibia (Core-NB)

COVID-19 | HIV Seropositivity | Tuberculosis, Pulmonary | Tuberculosis Infection

Namibia
ANRS, Emerging Infectious Diseases
Gilead Sciences

Not yet recruiting

A Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine and ténofovir alafénamide

HIV-1-infection

France
The Aurum Institute NPC
Johns Hopkins University; Weill Medical College of Cornell University; University...

Recruiting

Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV (DOLPHIN Moms)

Pregnancy | HIV Seropositivity | Tuberculosis Infection

South Africa
Brigham and Women's Hospital
University of Cape Town; APIN Public Health Initiatives

Recruiting

Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin

Tuberculosis Infection | Pediatric HIV Infection

Nigeria
UBP Greater China (Shanghai) Co., Ltd

Not yet recruiting

A Proof of Concept Study to Evaluate the Effect of UB-421 in Combination With Chidamide on HIV Viral Reservoir

HIV-1-infection
Kenya Medical Research Institute
European and Developing Countries Clinical Trials Partnership (EDCTP)

Recruiting

Latent HIV-1, Viral Suppress and Hope for HIV Cure

HIV-1-infection

Kenya
Steven Deeks
Caring Cross

Recruiting

CAR-T Cells for HIV Infection

HIV Infections

United States
Fundació Institut Germans Trias i Pujol
National Center for Tuberculosis and Lung Disease, Tbilisi, Georgia; Perinatal...

Recruiting

Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis (SMA-TB)

Tuberculosis, Pulmonary | Tuberculosis Infection | Tuberculosis, MDR

South Africa, Georgia
University of California, San Francisco
Chan Zuckerberg Biohub

Recruiting

SCOPE Analytic Treatment Interruption Protocol (SCOPE-ATI)

HIV/AIDS

United States
University College Dublin
University of Copenhagen; Rush University Medical Center

Recruiting

Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV (SWIFT)

Obesity | HIV-1-infection

Ireland
Guangzhou 8th People's Hospital
Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences

Recruiting

The Effect of Arsenic Trioxide on Eliminating HIV-1 Reservoir Combined With cART

HIV/AIDS

China

Search clinical trials for: HIV latent reservoir

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations